BackNOV Overview
NOV Inc

NOV Target Price

Analysts' average 12-month price target for NOV is $22.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.99

Average Target Price

$22.175.6% upside

6 analysts in the last 4 months

High: $26 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15Morgan Stanley$210% upsideOpen
2026-07-08Susquehanna$224.8% upsideOpen
2026-06-04Capital One Financial$2623.9% upsideOpen
2026-06-03Goldman Sachs$199.5% downsideOpen
2026-05-07BarclaysDavid Anderson$210% upsideOpen
2026-04-29Susquehanna$2414.3% upsideOpen
2026-04-15Morgan Stanley$204.7% downsideOpen
2026-02-09Piper SandlerDerek Podhaizer$1814.2% downsideOpen
2026-02-06Evercore ISIJason Bandel$199.5% downsideOpen
2026-02-06Stifel Nicolaus$210% upsideOpen
2026-02-06Susquehanna$210% upsideOpen
2026-01-15RBC CapitalKeith Mackey$210% upsideOpen
2026-01-14Goldman Sachs$1719% downsideOpen
2026-01-07SusquehannaCharles Minervino$204.7% downsideOpen
2025-12-18Piper SandlerDerek Podhaizer$1719% downsideOpen
2025-12-17Barclays$1528.5% downsideOpen
2025-12-15Morgan StanleyJoe Laetsch$1623.8% downsideOpen
2025-11-11BarclaysDavid Anderson$1338.1% downsideOpen
2025-11-05Goldman SachsAti Modak$1433.3% downsideOpen
2025-10-30Barclays$1433.3% downsideOpen
2025-10-29Stifel Nicolaus$199.5% downsideOpen
2025-10-29RBC Capital$199.5% downsideOpen
2025-10-28Raymond JamesJames Rollyson$1719% downsideOpen
2025-07-30Susquehanna$1719% downsideOpen
2025-04-15Stifel NicolausStephen Gengaro$239.6% upsideOpen
2025-03-24RBC CapitalKeith Mackey$224.8% upsideOpen
2024-12-18BarclaysDavid Anderson$1242.8% downsideOpen
2024-10-11Stifel NicolausStephen Gengaro$2519.1% upsideOpen
2024-10-10BMO CapitalPhillip Jungwirth$204.7% downsideOpen
2024-09-16Morgan StanleyDaniel Kutz$239.6% upsideOpen
2024-07-30BarclaysDavid Anderson$204.7% downsideOpen
2023-02-08Susquehanna$2938.2% upsideOpen
2022-07-29Morgan Stanley$199.5% downsideOpen
2022-07-13Morgan Stanley$1814.2% downsideOpen
2022-07-13Goldman Sachs$1623.8% downsideOpen
2022-06-08Barclays$224.8% upsideOpen
2022-05-02Barclays$204.7% downsideOpen
2022-02-04Evercore ISIJames West$224.8% upsideOpen
2021-12-09Cowen & Co.Marc Bianchi$199.5% downsideOpen
2021-10-11Morgan StanleyConnor Lynagh$1719% downsideOpen
2021-07-19BMO CapitalPhillip Jungwirth$1528.5% downsideOpen
2021-05-04Coker PalmerVaibhav Vaishnav$1242.8% downsideOpen

NOV (NOV) FAQ

As of the most recent data, NOV shows a target price of $22. Scroll down for historical charts and peer comparison views.

If NOV moved to the average analyst target of $22, shares would be roughly 5.6% higher than $20.99. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of NOV's earnings trajectory.

Besides this target price page, Stockcircle has NOV's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $22) with ownership activity and broader fundamentals.

NOV's target price is $22; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.